Oppenheimer & Co. Inc. has added seven senior professionals to its Institutional Derivatives business, all joining from Guggenheim Securities, with backgrounds across derivatives strategy, sales, trading, and technology.
Alon Rosin, who leads Oppenheimer’s Institutional Derivatives Sales and Trading desk, sees the expansion as something bigger than a hiring announcement. The bet underneath it is that institutional clients increasingly want a derivatives partner who can take an idea from its first spark through structuring and into execution without handing it off along the way.
A Senior Team Built for a More Specialized Market
Ed Boll joins as Head of Derivatives Strategy, giving idea generation a research-driven voice. Steve Ahn brings expertise in volatility trading, convertible securities and strategy development. Steven Weingroff covers institutional clients across AI infrastructure, high-performance computing, and crypto-related equities. Nick Colucci arrives with a specialized coverage focus in biotech and healthcare derivatives, built around catalyst- and event-driven trading tied to clinical data and regulatory decisions. Matthew Shaffer deepens the high-touch senior trading bench while Julia Marcus provides both Sales & Trading support. Jia Li is a highly ranked derivatives algo technology veteran, and Bill Visconto in an external advisory capacity.
A Deliberate Investment in a High-Margin Business
Oppenheimer has framed the hires as a meaningful step in scaling its institutional equities platform, specifically within derivatives, at a moment when client demand keeps moving toward more sophisticated, solutions-oriented engagement. The expansion serves a dual purpose: diversifying revenue while improving the firm’s ability to capture higher-value flow tied to structured, customized strategies rather than purely execution-based volume.
That fits Oppenheimer’s broader strategy of investing in high-margin, client-driven businesses where expertise and relationships actually differentiate a firm. Bringing in a senior, established derivatives team speeds up the push to become a more relevant partner for institutional clients who want idea generation, risk management, and tailored solutions in one place.
Three Capabilities the New Team Adds
Alon Rosin has pointed to three areas where the team materially strengthens the desk. Client franchise expansion comes first, with immediate access to a diversified, institutional-quality client base with deep, established relationships across hedge funds and asset managers. Then there’s strategy-led coverage, with Ed Boll heading a differentiated derivatives strategy capability focused on bespoke solutions, volatility positioning, and portfolio-level risk management. And finally, full-spectrum execution: strength across both high-touch and low-touch options execution, which lets the desk serve clients wherever they fall on the liquidity and complexity spectrum.
Taken together, Rosin has said, the combination meaningfully upgrades Oppenheimer’s ability to originate, structure, and execute complex derivatives transactions.
Linking Derivatives to the Rest of the Platform
The strategic logic runs past the derivatives desk itself. The expanded team is expected to work alongside Oppenheimer’s convertible bonds, high yield, cash equities, and prime services businesses, tightening the connectivity between cash equities, prime services, and derivatives.
For institutional clients, that connectivity carries real weight. A derivatives strategy almost never stands alone. A volatility view usually needs a cash equity position, a hedge, or financing through prime services before it’s fully expressed, and a desk that can coordinate across those businesses moves faster and offers a more complete solution than one that only executes the options leg and leaves the client to sort out the rest.
That connectivity is what lets the firm compete for larger, multi-product institutional relationships instead of being treated as a single-product desk.
John Hellier, Senior Managing Director and Head of Equities at Oppenheimer, called the expansion “an important investment in the continued development of our Institutional Equities platform,” adding that the team brings established institutional relationships and specialized expertise across strategy, sales, trading, and technology.
Oppenheimer’s own messaging around the announcement has stressed three takeaways for clients: expanded ability to deliver customized options strategies and actionable trade ideas, meaningfully greater senior coverage dedicated to institutional derivatives clients, and a more competitive alternative to larger platforms. Oppenheimer’s Institutional Derivatives Sales and Trading desk pair senior talent with a focused, high-service model.
A Career Shaped by Both Sides of the Trade
Rosin’s own background helps explain why an integration-first approach suits him. He spent nearly a decade as a portfolio manager and senior trader at hedge funds including J. Goldman & Co. and Diamondback Capital, then spent almost eighteen years running institutional sales and derivatives businesses on Wall Street, including a stint as Head of Institutional Sales for Derivatives & Equities, The Americas, at BGC Partners.
That nearly three decades of buy-side and sell-side trading experience gives him a practitioner’s read on how institutional investors actually think about risk, positioning, and liquidity, not a purely sell-side view of the relationship. His track record reflects that. Rosin drew attention in April 2025 for calling an apparent bottom during a period of extreme volatility, a conviction call that makes sense only from someone who has sat on both sides of the trade through past downturns.
There are no guarantees the newly built team performs on schedule, and integration risk is real whenever a firm absorbs a group of senior professionals at once. Institutional clients will judge the expansion on responsiveness and idea quality over the next several quarters, not on the announcement itself.
Still, the specialization of the new hires, combined with the cross-desk connectivity Oppenheimer is deliberately building, points to something beyond added headcount. The firm is trying to make its Institutional Derivatives business a more complete answer for clients who want strategy, structuring, and execution from the same team, and Alon Rosin is the person now responsible for making that promise hold up in practice.
